Kevin McElgunn
Corporate Officer/Principal chez MYERS INDUSTRIES, INC.
Profil
Mr. Kevin McElgunn is Investment Director at Dow Chemical Corporate Venture Capital.
Mr. McElgunn joined Dow in 1985, progressing through a variety of sales, marketing and business management positions, primarily in Dow Specialty Chemicals businesses.
In 2002, he was named Business Director and General Manager, Biopharmaceutical Contract Manufacturing Services of DowPharma.
He joined the Dow Ventures group in 2004 as Platform Director, responsible for identifying, developing and implementing new business options aligned with Dow’s strategic interests.
In late 2005, he joined Dow’s Corporate Development group, identifying transformational enterprise-level opportunities.
McElgunn assumed his current role in late 2007.
Mr. McElgunn earned a Bachelors of Science degree in Chemical Engineering at Kansas State University in 1984, and an MBA at Northwood University in 1997.
Postes actifs de Kevin McElgunn
Sociétés | Poste | Début |
---|---|---|
MYERS INDUSTRIES, INC. | Corporate Officer/Principal | 01/06/2022 |
Anciens postes connus de Kevin McElgunn
Sociétés | Poste | Fin |
---|---|---|
Dow Chemical Corporate Venture Capital
Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Private Equity Investor | 01/03/2018 |
PFENEX INC. | Directeur/Membre du Conseil | - |
Formation de Kevin McElgunn
Kansas State University | Undergraduate Degree |
Northwood University (Michigan) | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MYERS INDUSTRIES, INC. | Producer Manufacturing |
Entreprise privées | 2 |
---|---|
Dow Chemical Corporate Venture Capital
Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Finance |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |